DexCom (DXCM) Short Interest Ratio & Short Volume $66.88 -0.17 (-0.25%) As of 02:34 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DexCom Short Interest DataDexCom (DXCM) has a short interest of 13.14 million shares. This marks a 18.38% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.9, indicating that it would take 2.9 days of the average trading volume of 4.20 million shares to cover all short positions.Current Short Interest13,140,000 sharesPrevious Short Interest11,100,000 sharesChange Vs. Previous Month+18.38%Dollar Volume Sold Short$993.12 millionShort Interest Ratio2.9 Days to CoverLast Record DateSeptember 15, 2025Outstanding Shares392,155,000 sharesPercentage of Shares Shorted3.35%Today's Trading Volume2,442,577 sharesAverage Trading Volume4,199,924 sharesToday's Volume Vs. Average58% Short Selling DexCom? Sign up to receive the latest short interest report for DexCom and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartDXCM Short Interest Over TimeDXCM Days to Cover Over TimeDXCM Percentage of Float Shorted Over Time DexCom Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/202513,140,000 shares $993.12 million +18.4%N/A2.9 $75.58 8/31/202511,100,000 shares $836.27 million +12.1%2.8%2.9 $75.34 8/15/20259,900,000 shares $801.41 million +16.6%N/A2.8 $80.95 7/31/20258,490,000 shares $685.74 million -4.5%2.2%2.4 $80.77 7/15/20258,890,000 shares $753.69 million -15.4%N/A2.5 $84.78 6/30/202510,510,000 shares $917.42 million +12.1%2.7%2.6 $87.29 6/15/20259,380,000 shares $769.07 million -9.9%2.4%2.3 $81.99 5/31/202510,410,000 shares $894.84 million -7.7%2.7%2.5 $85.96 5/15/202511,280,000 shares $966.36 million -1.1%2.9%2.6 $85.67 4/30/202511,410,000 shares $814.45 million +7.5%N/A2.5 $71.38 Get the Latest News and Ratings for DXCM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DexCom and its competitors with MarketBeat's FREE daily newsletter. 4/15/202510,610,000 shares $734.53 million -3.6%2.7%2.5 $69.23 3/31/202511,010,000 shares $751.87 million -4.0%2.8%2.7 $68.29 3/15/202511,470,000 shares $810.81 million +16.2%2.9%3 $70.69 2/28/20259,870,000 shares $872.21 million +4.1%2.5%2.7 $88.37 2/15/20259,480,000 shares $844.38 million -3.8%2.4%2.7 $89.07 1/31/20259,850,000 shares $855.28 million +11.8%N/A2.8 $86.83 1/15/20258,810,000 shares $708.32 million +0.1%N/A2.2 $80.40 12/31/20248,800,000 shares $684.38 million -5.7%N/A2.3 $77.77 12/15/20249,330,000 shares $720.18 million +10.8%N/A2.3 $77.19 11/30/20248,420,000 shares $656.68 million -7.7%N/A2 $77.99 11/15/20249,120,000 shares $692.03 million -2.6%N/A2.1 $75.88 10/31/20249,360,000 shares $659.69 million +21.9%N/A2.2 $70.48 10/15/20247,680,000 shares $515.33 million -19.6%N/A1.3 $67.10 9/30/20249,550,000 shares $640.23 million +11.7%N/A1.7 $67.04 9/15/20248,550,000 shares $594.31 million +16.6%N/A1.6 $69.51 8/31/20247,330,000 shares $508.26 million -3.0%N/A1.4 $69.34 8/15/20247,560,000 shares $547.04 million +7.2%N/A1.5 $72.36 7/31/20247,050,000 shares $478.13 million -32.3%N/A1.5 $67.82 7/15/202410,420,000 shares $1.18 billion +1.1%N/A3.8 $113.01 6/30/202410,310,000 shares $1.17 billion +14.4%N/A3.8 $113.38 6/15/20249,010,000 shares $1.04 billion +3.1%N/A3.2 $115.95 5/31/20248,740,000 shares $1.04 billion +12.3%N/A3.2 $118.77 5/15/20247,780,000 shares $1.01 billion -29.9%N/A2.7 $129.71 4/30/202411,100,000 shares $1.41 billion -5.7%N/A3.6 $127.39 4/15/202411,770,000 shares $1.58 billion -19.2%N/A3.9 $134.56 3/31/202414,570,000 shares $2.02 billion -8.2%N/A4.7 $138.70 3/15/202415,870,000 shares $2.07 billion -4.7%N/A5.3 $130.46 2/29/202416,650,000 shares $1.92 billion -2.5%N/A5.4 $115.07 2/15/202417,070,000 shares $2.01 billion -8.0%N/A5.7 $117.69 1/31/202418,560,000 shares $2.25 billion +1.8%N/A5.9 $121.35 1/15/202418,240,000 shares $2.28 billion -0.9%N/A5 $125.00 12/31/202318,410,000 shares $2.28 billion -2.9%N/A4.4 $124.09 12/15/202318,960,000 shares $2.32 billion -0.8%N/A4.1 $122.59 11/30/202319,120,000 shares $2.21 billion +7.7%N/A3.9 $115.52 11/15/202317,750,000 shares $1.81 billion -15.7%N/A3.4 $102.11 10/31/202321,060,000 shares $1.87 billion +30.7%N/A4.2 $88.83 10/15/202316,110,000 shares $1.23 billion +2.0%N/A3.5 $76.19 9/30/202315,800,000 shares $1.47 billion -1.4%N/A3.8 $93.30 9/15/202316,030,000 shares $1.54 billion -5.3%N/A4.4 $96.35 8/31/202316,920,000 shares $1.71 billion +0.8%N/A5 $100.98 8/15/202316,780,000 shares $1.92 billion +11.9%N/A5.4 $114.51 7/31/202315,000,000 shares $1.87 billion +21.2%N/A5.3 $124.56 7/15/202312,380,000 shares $1.70 billion -0.2%N/A4.7 $137.32 6/30/202312,410,000 shares $1.59 billion -2.4%N/A5 $128.51 6/15/202312,710,000 shares $1.66 billion -10.9%N/A5.3 $130.98 5/31/202314,260,000 shares $1.67 billion -1.4%N/A6.3 $117.26 5/15/202314,460,000 shares $1.73 billion +13.6%N/A6.5 $119.61 4/30/202312,730,000 shares $1.54 billion +5.4%N/A5.4 $121.34 4/15/202312,080,000 shares $1.40 billion -2.7%N/A5.3 $115.70 3/31/202312,410,000 shares $1.44 billion -1.4%N/A5.1 $116.18 3/15/202312,580,000 shares $1.43 billion -2.7%N/A5.1 $113.72 2/28/202312,930,000 shares $1.44 billion -2.0%N/A4.9 $111.01 2/15/202313,190,000 shares $1.59 billion +18.7%N/A5 $120.17 1/31/202311,110,000 shares $1.19 billion -5.6%N/A4.4 $107.09 1/15/202311,770,000 shares $1.28 billion +1.0%N/A4.3 $108.47 12/30/202211,650,000 shares $1.32 billion -7.0%N/A4.2 $113.24 12/15/202212,530,000 shares $1.46 billion -3.4%N/A4.3 $116.24 11/30/202212,970,000 shares $1.51 billion +3.0%N/A4.6 $116.28 11/15/202212,590,000 shares $1.46 billion +5.8%N/A4.5 $116.31 10/31/202211,900,000 shares $1.44 billion -13.1%N/A4.3 $120.78 10/15/202213,690,000 shares $1.33 billion +4.5%N/A4.8 $97.41 9/30/202213,100,000 shares $1.06 billion -14.1%N/A4.8 $80.54 9/15/202215,250,000 shares $1.39 billion +6.3%N/A5.9 $90.98 8/31/202214,350,000 shares $1.18 billion +7.2%N/A5.2 $82.21 8/15/202213,390,000 shares $1.24 billion +10.2%N/A4 $92.30 7/31/202212,150,000 shares $997.27 million +3.5%N/A3.3 $82.08 7/15/202211,740,000 shares $929.10 million -3.0%N/A3.3 $79.14 6/30/202212,100,000 shares $901.81 million -6.9%N/A3.4 $74.53 6/15/202213,000,000 shares $929.63 million +293.9%14.8%3.6 $71.51 5/31/20223,300,000 shares $245.80 million -10.6%N/A3.7 $74.49 5/15/20223,690,000 shares $1.24 billion +10.5%N/A4.5 $334.74 4/30/20223,340,000 shares $1.36 billion -3.2%N/A4.2 $408.58 4/15/20223,450,000 shares $1.70 billion -2.8%3.6%4.4 $492.11 3/31/20223,550,000 shares $1.82 billion +4.1%3.7%4 $511.60 3/15/20223,410,000 shares $1.42 billion +0.6%3.6%4.1 $416.08 2/28/20223,390,000 shares $1.40 billion -1.5%3.5%3.8 $413.91 2/15/20223,440,000 shares $1.44 billion +7.2%3.6%3.8 $417.51 1/31/20223,210,000 shares $1.38 billion -3.3%3.4%3.9 $430.48 1/15/20223,320,000 shares $1.49 billion +8.9%N/A4.2 $447.34 12/31/20213,050,000 shares $1.64 billion -1.9%3.2%4.2 $536.95 12/15/20213,110,000 shares $1.68 billion -12.6%3.3%4.7 $541.29 11/30/20213,560,000 shares $2.00 billion -2.5%3.7%5.9 $562.59 11/15/20213,650,000 shares $2.34 billion +0.3%3.8%6.8 $641.95 10/29/20213,640,000 shares $2.27 billion +4.6%3.8%6.9 $623.21 10/15/20213,480,000 shares $1.89 billion +1.5%3.7%6.2 $544.47 9/30/20213,430,000 shares $1.88 billion -5.3%3.6%6 $546.86 9/15/20213,620,000 shares $2.00 billion -6.0%3.8%5.6 $551.67 8/31/20213,850,000 shares $2.04 billion -3.3%4.1%5.7 $529.42 8/13/20213,980,000 shares $1.96 billion -5.9%4.2%5.5 $491.41 7/30/20214,230,000 shares $2.18 billion -1.9%4.5%5.4 $515.51 7/15/20214,310,000 shares $1.90 billion +5.6%4.5%5.4 $441.42 6/30/20214,080,000 shares $1.74 billion +6.8%4.3%5.1 $427.00 6/15/20213,820,000 shares $1.55 billion +3.5%4.0%5 $405.10 5/28/20213,690,000 shares $1.36 billion -1.6%3.9%4.8 $369.39 5/14/20213,750,000 shares $1.21 billion +5.3%N/A4.7 $323.96 4/30/20213,560,000 shares $1.50 billion -2.2%N/A4.5 $421.70 4/15/20213,640,000 shares $1.42 billion +2.0%N/A4.8 $391.10 3/31/20213,570,000 shares $1.24 billion -3.0%N/A4.3 $347.20 3/15/20213,680,000 shares $1.32 billion -5.4%N/A4.2 $357.73 2/26/20213,890,000 shares $1.54 billion +2.9%N/A4.2 $395.47 2/12/20213,780,000 shares $1.55 billion +0.5%N/A3.9 $410.20 1/29/20213,760,000 shares $1.38 billion -0.3%N/A3.8 $366.89 1/15/20213,770,000 shares $1.33 billion +9.3%N/A3.2 $352.08 12/31/20203,450,000 shares $1.25 billion -1.2%N/A2.9 $362.77 12/15/20203,490,000 shares $1.23 billion +19.9%N/A3.1 $353.59 11/30/20202,910,000 shares $925.99 million +7.4%N/A2.7 $318.21 11/15/20202,710,000 shares $911.64 million -1.1%N/A2.6 $336.40 10/30/20202,740,000 shares $918.69 million -31.0%N/A2.9 $335.29 10/15/20203,970,000 shares $1.56 billion -4.1%N/A5.1 $394.01 DXCM Short Interest - Frequently Asked Questions What is DexCom's current short interest? Short interest is the volume of DexCom shares that have been sold short but have not yet been closed out or covered. As of September 15th, traders have sold 13,140,000 shares of DXCM short. Learn More on DexCom's current short interest. What is a good short interest ratio for DexCom? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DXCM shares currently have a short interest ratio of 3.0. Learn More on DexCom's short interest ratio. Which institutional investors are shorting DexCom? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of DexCom: Group One Trading LLC, BNP Paribas Financial Markets, Balyasny Asset Management L.P., Bank of America Corp DE, Jane Street Group LLC, Caption Management LLC, Qube Research & Technologies Ltd, Maven Securities LTD, Walleye Capital LLC, Walleye Trading LLC, Lido Advisors LLC, Hsbc Holdings PLC, Capital Fund Management S.A., Jefferies Financial Group Inc., Eisler Capital Management Ltd., JPMorgan Chase & Co., SG Capital Management LLC, SG Americas Securities LLC, Garda Capital Partners LP, Wolverine Asset Management LLC, and Twin Tree Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is DexCom's short interest increasing or decreasing? DexCom saw a increase in short interest in September. As of September 15th, there was short interest totaling 13,140,000 shares, an increase of 18.4% from the previous total of 11,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does DexCom's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to DexCom: HealthEquity, Inc. (5.12%), Insulet Corporation (2.13%), Abbott Laboratories (1.04%), AMN Healthcare Services Inc (8.71%), Integer Holdings Corporation (6.94%), Becton, Dickinson and Company (1.50%), IDEXX Laboratories, Inc. (2.68%), Edwards Lifesciences Corporation (1.26%), ResMed Inc. (5.95%), STERIS plc (1.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks. What does it mean to sell short DexCom stock? Short selling DXCM is an investing strategy that aims to generate trading profit from DexCom as its price is falling. DXCM shares are trading up $0.61 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against DexCom? A short squeeze for DexCom occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DXCM, which in turn drives the price of the stock up even further. How often is DexCom's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DXCM, twice per month. The most recent reporting period available is September, 15 2025. More Short Interest Resources from MarketBeat Related Companies HealthEquity Short Squeeze Insulet Short Squeeze Abbott Laboratories Short Squeeze AMN Healthcare Services Short Squeeze Integer Short Squeeze Becton, Dickinson and Company Short Squeeze IDEXX Laboratories Short Squeeze Edwards Lifesciences Short Squeeze ResMed Short Squeeze STERIS Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DXCM) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredThe next wave of AI fortunes may come from NVIDIA’s secret supplier.Bloomberg says AI is a $50 trillion revolution. And at the center of it… isn't NVIDIA. It's a tiny suppl...Behind the Markets | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredRIP USA"The America you knew is dying in front of you" That's the urgent warning the former $200 million hedge fun...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DexCom, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DexCom With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
